Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126mg/dL

Hepatology Research

Volumn 42, Issue 6, 2012, Pages 558-563

  Matsumoto, Naoki ^a   Arase, Yasuji ^a,b   Seko, Yuya ^a   Imai, Norihiro ^a   Kawamura, Yusuke ^a   Sezaki, Hitomi ^a   Hosaka, Tetsuya ^a   Akuta, Norio ^a   Kobayashi, Mariko ^a   Kobayashi, Masahiro ^a   Suzuki, Yoshiyuki ^a   Saito, Satoshi ^a   Suzuki, Fumitaka ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a   Aida, Kaoru ^c   Kobayashi, Tetsuro ^c  

^a Okinaka Memorial Institute for Medical Research   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Diabetes mellitus; Hepatitis virus; Liver cirrhosis; Oral glucose tolerance test

Indexed keywords

GLUCOSE; INDOCYANINE GREEN; INSULIN; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; INSULIN BLOOD LEVEL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

EID: 84860668866     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00957.x     Document Type: Article

References (26)

1. Kiyosawa K, Furuta S. Review of hepatitis C in Japan. J Gastroenterol Hepatol 1991; 6: 383-91.
2. Alter MJ, Margolis HS, Krawczynski K etal. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-905.
3. van Rossum TG, Vulto AG, de Man RA etal. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 1998; 12: 199-205.
4. Colombo M, Kuo G, Choo QL etal. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006-8.
5. Hasan F, Jeffers LJ, De Medina M etal. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589-91.
6. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873-4.
7. Tsukuma H, Hiyama T, Tanaka S etal. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-801.
8. Ikeda K, Saitoh S, Koida I etal. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
9. Imazeki F, Yokosuka O, Fukai K etal. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Liver Int 2008; 28: 355-62.
10. Arao M, Murase K, Kusakabe A etal. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003; 38: 355-60.
11. Arase Y, Suzuki F, Suzuki Y etal. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 2009; 49: 739-44.
12. Rouabhia S, Malek R, Bounecer H etal. Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol 2010; 16: 3427-31.
13. Kawamura Y, Arase Y, Ikeda K etal. Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients. Am J Med 2010; 123: 951-6.e1.
14. Veldt BJ, Chen W, Heathcote EJ etal. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008; 47: 1856-62.
15. Imai K, Takai K, Nishigaki Y etal. Insulin resistance raises the risk for recurrence of stage 1 hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients. Hepatol Res 2010; 40: 376-82.
16. Genuth S, Alberti KG, Bennett P etal. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
17. Arase Y, Suzuki F, Suzuki Y etal. Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses. Hepatol Res 2008; 38: 877-85.
18. Caronia S, Taylor K, Pagliaro L etal. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
19. Mason AL, Lau JY, Hoang N etal. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
20. Mangia A, Schiavone G, Lezzi G etal. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998; 93: 2363-7.
21. Custro N, Carroccio A, Ganci A etal. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001; 27: 476-81.
22. Quintana JO, García-Compean D, González JA etal. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Ann Hepatol 2011; 10: 56-62.
23. El-Serag HB, Hran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.
24. Nishida T, Tsuji S, Tsuji M etal. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006; 101: 70-5.
25. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 15: 280-8.
26. Koga M, Kasayama S, Kanehara H, Bando Y. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008; 81: 258-62.